C3 glomerulopathy: a new classification - PubMed (original) (raw)

Review

C3 glomerulopathy: a new classification

Fadi Fakhouri et al. Nat Rev Nephrol. 2010 Aug.

Abstract

Several distinct pathological patterns of glomerular inflammation are associated with abnormal regulation of the complement system, specifically, with dysregulation of the alternative pathway of the complement system. However, these conditions share the pathological finding of complement C3 (C3) deposited within the glomerulus in the absence of substantial immunoglobulin. This finding has alerted us and others to the possible presence of genetic and acquired complement dysregulation in individual patients. This article summarizes our current understanding of the relationship between dysregulation of the complement system and glomerular inflammation. Here, we suggest that glomerular pathologies that are characterized by the isolated deposition of C3 could usefully be classified by the term C3 glomerulopathy. In our view, this classification would alert the pathologist and nephrologist to the importance of screening for acquired and genetic abnormalities in complement regulation. In the future, it could help to identify individuals who might benefit from therapeutic inhibition of the complement system.

PubMed Disclaimer

References

    1. J Am Soc Nephrol. 2007 Sep;18(9):2447-56 - PubMed
    1. Clin Exp Immunol. 2008 Feb;151(2):210-30 - PubMed
    1. J Am Soc Nephrol. 2002 Aug;13(8):2052-7 - PubMed
    1. Nat Rev Drug Discov. 2010 Jan;9(1):43-56 - PubMed
    1. Kidney Int. 1975 Apr;7(4):204-15 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources